Healthcare - Biotechnology - NASDAQ - US
$ 13.98
-5.67 %
$ 1.27 B
Market Cap
-5.12
P/E
Price Target
Average
187.91%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
38.10%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rocket Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RCKT of $40.2 , with forecasts ranging from a low of $38 to a high of $45 .
RCKT Lowest Price Target
Wall Street Target
38 USD
171.82%
RCKT Average Price Target
Wall Street Target
40.2 USD
187.91%
RCKT Highest Price Target
Wall Street Target
45 USD
221.89%
REVENUE FORECAST
Revenue Forecast Chart RCKT
EBIT FORECAST
EBIT Forecast Chart RCKT
NET INCOME FORECAST
Net Income Chart RCKT